Recro Reports Inducement Grants For New Staff

EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced the expansion of its team through the addition of new employees to support product development, business development, quality, technical operations, functional support roles and to enhance leadership in the company’s San Diego operations.

Read more at globenewswire.com